SS-31 Peptide Guide 2026: Benefits, Dosage & Where to Buy?

If you have been researching ways to boost mitochondrial health, slow aging, or enhance cellular energy production, you have likely come across SS-31. This synthetic tetrapeptide has generated significant interest in the longevity and biohacking communities.

SS-31 (elamipretide) is a mitochondria-targeted peptide that binds to cardiolipin in the inner mitochondrial membrane, enhancing ATP production while reducing oxidative stress. In 2026, it received FDA accelerated approval under the brand name Forzinity for treating Barth syndrome.

I have spent considerable time reviewing the clinical research, user experiences, and practical protocols for SS-31. This guide covers everything you need to know: how it works, the research-backed benefits, proper dosing protocols, potential side effects, and where to find quality sources.

ContentsTable of Contents

1. 1What Is SS-31 (Elamipretide)?→
2. 2How Does SS-31 Work? Mechanism of Action→
3. 3Is SS-31 FDA Approved?→
4. 4SS-31 Benefits: What Research Shows→
5. 5Enhanced Mitochondrial Function and ATP Production→
6. 6Anti-Aging and Longevity Effects→
7. 7Cognitive Function and Neuroprotection→
8. 8Cardiovascular Protection→
9. 9Muscle Performance and Recovery→
10. 10Kidney Protection→
11. 11SS-31 Dosage Protocol: Complete Guide→
12. 12Standard Dosage Protocol→
13. 13Advanced Dosage Protocol→
14. 14Reconstitution Instructions→
15. 15Storage Guidelines→
16. 16Cycling Recommendations→
17. 17SS-31 Side Effects and Safety→
18. 18Common Side Effects→
19. 19Contraindications→
20. 20Long-Term Safety Considerations→
21. 21SS-31 vs MOTS-C vs Humanin: Mitochondrial Peptide Comparison→
22. 22Key Differences Explained→
23. 23Which Should You Consider?→
24. 24Where to Buy SS-31 Peptide?→
25. 25Pure Lab Peptides→
26. 26Pros→
27. 27Cons→
28. 28PurePeptides.vip→
29. 29Pros→
30. 30Cons→
31. 31What to Look for in a Peptide Vendor?→
32. 32Frequently Asked Questions→
33. 33How long does SS-31 take to work?→
34. 34Can you stack SS-31 with other peptides?→
35. 35How do you store SS-31 peptide?→
36. 36Is SS-31 legal to buy?→
37. 37What is the cost of SS-31?→
38. 38How do you reconstitute SS-31?→
39. 39Final Thoughts on SS-31→

What Is SS-31 (Elamipretide)?

SS-31 is a synthetic aromatic tetrapeptide designed to target and protect mitochondria. The peptide derives its name from Hazel Szeto and Peter Bhimji Schiller, the researchers who developed it.

You may encounter SS-31 under several names including elamipretide, Bendavia, MTP-131, or the FDA-approved brand name Forzinity. These all refer to the same compound with the molecular formula D-Arg-2′,6′-dimethylTyr-Lys-Phe-NH2 and a molecular weight of 639.8 g/mol.

What makes SS-31 unique among peptides is its ability to selectively accumulate in the inner mitochondrial membrane. Unlike many antioxidants that struggle to reach mitochondria, SS-31 concentrates at 1000-5000 times higher levels inside these cellular powerhouses.

The peptide was originally developed by Stealth BioTherapeutics to address diseases caused by mitochondrial dysfunction. Clinical trials have examined its effects on heart failure, kidney disease, and primary mitochondrial myopathy.

In January 2026, the FDA granted accelerated approval for elamipretide (Forzinity) to treat Barth syndrome, a rare genetic disorder affecting mitochondrial function. This marked a significant milestone as the first FDA-approved treatment specifically targeting mitochondrial cardiolipin.

How Does SS-31 Work? Mechanism of Action

SS-31 works by targeting cardiolipin, a phospholipid found exclusively in the inner mitochondrial membrane. Understanding this mechanism helps explain why researchers believe the peptide may support mitochondrial health.

Here is how SS-31 affects mitochondrial function according to published research:

1. Cardiolipin Binding: SS-31 selectively binds to cardiolipin through electrostatic and hydrophobic interactions. This binding helps stabilize the structure and function of electron transport chain complexes embedded in the inner mitochondrial membrane.
2. Electron Transport Chain Optimization: By stabilizing cardiolipin, SS-31 may help maintain proper organization of electron transport chain supercomplexes. Research suggests this can enhance electron transfer efficiency between complexes I, III, and IV.
3. Cytochrome C Function: SS-31 appears to promote the electron carrier function of cytochrome c while inhibiting its peroxidase activity. This shift may help reduce reactive oxygen species (ROS) production at the mitochondrial level.
4. ATP Synthesis Enhancement: With improved electron transport chain function, mitochondria may produce ATP more efficiently. Studies have shown SS-31 can increase ATP synthesis rates in various tissue types.
5. Mitochondrial Permeability Transition Pore (mPTP) Protection: Research indicates SS-31 may help prevent pathological opening of the mPTP, which can trigger cell death during stress or injury.

The peptide does not function as a direct antioxidant in the traditional sense. Instead, it appears to work by optimizing mitochondrial electron flow, which reduces the electron leak that generates damaging reactive oxygen species in the first place.

This mechanism explains why SS-31 has been studied for conditions ranging from heart failure to neurodegenerative diseases. Mitochondrial dysfunction underlies many age-related conditions, making mitochondria-targeted interventions an active area of research.

Is SS-31 FDA Approved?

Yes, SS-31 received FDA approval in January 2026, but with important limitations. The approval was specifically for elamipretide injection under the brand name Forzinity for treating Barth syndrome only.

Barth syndrome is a rare, life-threatening genetic disorder that primarily affects males. The condition is caused by mutations in the TAFAZZIN gene, which leads to abnormal cardiolipin remodeling and severe mitochondrial dysfunction affecting the heart and skeletal muscles.

The FDA granted accelerated approval based on improvements in the six-minute walk test, a standard measure of exercise capacity. This approval means Forzinity is available by prescription from healthcare providers for patients with confirmed Barth syndrome.

For individuals without Barth syndrome, SS-31 remains available only as a research compound. Clinical trials continue to evaluate its potential for other conditions including heart failure, primary mitochondrial myopathy, and age-related macular degeneration.

SS-31 Benefits: What Research Shows

Based on our review of published research and clinical trial data, SS-31 has shown potential benefits across several areas. The following benefits are based on preclinical and clinical studies, and individual results may vary.

Enhanced Mitochondrial Function and ATP Production

The primary mechanism of SS-31 centers on improving mitochondrial bioenergetics. Studies suggest the peptide may enhance ATP synthesis by optimizing electron transport chain function.

Research in animal models has demonstrated increased ATP production rates following SS-31 administration. Human studies in heart failure patients showed improvements in mitochondrial function markers in heart tissue samples.

Users interested in longevity and anti-aging often cite improved cellular energy as a primary reason for interest in this peptide.

Anti-Aging and Longevity Effects

Mitochondrial dysfunction is considered a hallmark of aging. As we age, our mitochondria become less efficient, producing less ATP and more reactive oxygen species.

Research suggests SS-31 may help address age-related mitochondrial decline. Animal studies have shown the peptide can improve mitochondrial function in aged tissues, potentially supporting healthier aging at the cellular level.

Studies in aged mice demonstrated that SS-31 improved mitochondrial energetics and reduced oxidative damage in skeletal muscle. These findings have generated interest in the peptide for age-related muscle loss (sarcopenia).

Cognitive Function and Neuroprotection

The brain has extremely high energy demands, making it particularly vulnerable to mitochondrial dysfunction. SS-31 has been studied for potential neuroprotective effects.

Preclinical research suggests SS-31 may protect against mitochondrial dysfunction in the hippocampus, the brain region critical for memory. Animal studies have shown improvements in cognitive function and reduced markers of neuroinflammation.

Research is ongoing to evaluate whether these neuroprotective effects translate to humans, particularly for age-related cognitive decline and neurodegenerative conditions.

Cardiovascular Protection

The heart is one of the most mitochondria-rich organs in the body, making it a natural target for mitochondria-targeted therapies. SS-31 has been extensively studied for cardiovascular applications.

Clinical trials have evaluated SS-31 for heart failure with reduced ejection fraction. While results have been mixed, some studies showed improvements in cardiac function markers and exercise capacity.

Animal studies have demonstrated that SS-31 may protect heart tissue during ischemia-reperfusion injury, the damage that occurs when blood flow is restored after a heart attack.

Muscle Performance and Recovery

Given the importance of mitochondria for muscle energy production, SS-31 has attracted interest for muscle performance applications.

Research in aged animals showed SS-31 improved exercise capacity and muscle strength. The peptide appeared to enhance mitochondrial function in skeletal muscle, potentially supporting better endurance and recovery.

Some researchers have explored SS-31 for conditions like primary mitochondrial myopathy, where muscle weakness results from inherited mitochondrial dysfunction.

Kidney Protection

The kidneys require significant energy for filtration and have high concentrations of mitochondria. SS-31 has shown promise in animal models of kidney disease.

Published research demonstrates that SS-31 may protect against acute kidney injury by preserving mitochondrial function during periods of reduced blood flow. Studies have shown reduced kidney damage markers and improved recovery.

Clinical trials have examined SS-31 for protecting kidney function during cardiac surgery, when the kidneys are vulnerable to ischemia-related damage.

SS-31 Dosage Protocol: Complete Guide

The following dosage information is compiled from research peptide protocols and clinical trial data. These are not medical recommendations, and anyone considering SS-31 should consult with a qualified healthcare provider.

Standard Dosage Protocol

Week	Daily Dose	Frequency	Notes
Weeks 1-2	5mg	Once daily	Assessment period for tolerance
Weeks 3-8	10mg	Once daily	Standard maintenance dose

The standard protocol begins with a lower dose to assess individual tolerance. Most research protocols suggest subcutaneous injection as the administration route.

Advanced Dosage Protocol

Week	Daily Dose	Frequency	Notes
Weeks 1-2	5mg	Once daily	Assessment period
Weeks 3-4	10mg	Once daily	Building phase
Weeks 5-8	15mg	Split into 2 doses	Higher dose phase
Weeks 9-12	20mg (optional)	Split into 2 doses	Maximum dose phase

Advanced protocols with higher doses require careful monitoring. The FDA-approved dosing for Barth syndrome uses 40mg daily, but this is under medical supervision for a specific condition.

Reconstitution Instructions

SS-31 typically comes as a lyophilized (freeze-dried) powder that requires reconstitution before use. Here is a standard approach:

1. Gather supplies: bacteriostatic water, alcohol swabs, insulin syringes
2. Add 3.0mL bacteriostatic water to a 30mg vial (creates 10mg/mL concentration)
3. Inject water slowly against the vial wall, not directly onto powder
4. Gently swirl until fully dissolved (do not shake vigorously)
5. Store reconstituted peptide in refrigerator at 2-8 degrees Celsius

Storage Guidelines

Form	Temperature	Stability
Lyophilized (powder)	-20 degrees Celsius (freezer)	Long-term storage
Reconstituted (liquid)	2-8 degrees Celsius (refrigerator)	Use within 4 weeks

Important storage notes: Avoid freeze-thaw cycles with reconstituted peptide. Protect from light exposure. The amber vials used by some vendors help maintain stability.

Cycling Recommendations

Research protocols typically run for 8-12 weeks. Limited data exists on benefits or risks of longer-term continuous use.

Some protocols suggest cycling with periods off the peptide, though optimal cycling patterns have not been established through clinical research.

SS-31 Side Effects and Safety

Based on clinical trial data and research reports, SS-31 appears to have a relatively mild side effect profile. However, as with any peptide, individual responses may vary.

Common Side Effects

The most frequently reported side effects from clinical trials include:

• Injection site reactions: Redness, itching, or mild swelling at the injection site
• Headache: Mild to moderate headaches, typically resolving without intervention
• Dizziness: Occasional lightheadedness, usually temporary
• Flushing: Warmth or redness of the skin
• Fatigue: Some users report temporary tiredness

Most side effects reported in clinical trials were mild to moderate in severity and did not require discontinuation of treatment.

Contraindications

SS-31 should be avoided by individuals in the following categories:

• Pregnant or breastfeeding women (insufficient safety data)
• Individuals with a history of cancer (theoretical concerns about cellular proliferation)
• Those with known hypersensitivity to peptide components
• People taking medications that may interact with mitochondrial function

Long-Term Safety Considerations

Clinical trials have primarily evaluated SS-31 over periods of weeks to months. Limited data exists on very long-term use beyond the duration of completed studies.

The FDA approval for Barth syndrome included requirements for ongoing safety monitoring, reflecting the need for more long-term data collection.

SS-31 vs MOTS-C vs Humanin: Mitochondrial Peptide Comparison

SS-31 is not the only peptide targeting mitochondrial function. MOTS-C and Humanin are two other peptides that have gained attention in the longevity community. Understanding their differences can help clarify which may be most relevant for specific interests.

Key Differences Explained

SS-31 is unique as a synthetic peptide specifically designed to target cardiolipin. It works primarily at the inner mitochondrial membrane to optimize electron transport chain function. The FDA approval for Barth syndrome provides validation of its mechanism.

MOTS-C is a naturally occurring peptide encoded within mitochondrial DNA. Research suggests it primarily affects metabolic pathways, improving insulin sensitivity and glucose metabolism. It has gained particular interest among those focused on metabolic health and exercise performance.

Humanin is another naturally occurring mitochondria-derived peptide with broader protective functions. Research has focused on its potential neuroprotective effects and role in cellular stress responses. It appears to have anti-apoptotic (cell death prevention) properties.

Which Should You Consider?

The choice between these peptides depends on individual goals and health focus:

• For mitochondrial dysfunction focus: SS-31 may be most relevant given its targeted mechanism
• For metabolic health and insulin sensitivity: MOTS-C has shown promise in this area
• For general longevity and neuroprotection: Humanin research covers broader applications

Some researchers explore combinations of mitochondrial peptides, though scientific data on stacking protocols remains limited.

Where to Buy SS-31 Peptide?

For researchers seeking SS-31 for laboratory purposes, quality sourcing is essential. Research peptides vary significantly in purity and authenticity between vendors.

Based on our research, the following vendors are recommended for research-grade SS-31:

Pure Lab Peptides provides documentation including Certificates of Analysis for each batch. The cold-chain shipping helps ensure the peptide arrives in optimal condition.

The amber vial packaging from PurePeptides.vip helps protect the peptide from light degradation. The ISO certification indicates quality management standards are in place.

What to Look for in a Peptide Vendor?

When sourcing research peptides, consider these quality indicators:

• Third-party testing: Independent lab verification of purity and identity
• Certificates of Analysis: Documentation for each batch showing purity levels
• Proper shipping: Cold-chain or temperature-controlled shipping for peptide stability
• Established reputation: Track record in the research peptide community
• Transparent practices: Clear information about sourcing and quality control

Frequently Asked Questions

Final Thoughts on SS-31

SS-31 represents an interesting development in the field of mitochondria-targeted therapeutics. The 2026 FDA approval for Barth syndrome validates the underlying mechanism, even if broad applications remain in the research phase.

For those interested in mitochondrial health and longevity, SS-31 offers a more direct approach compared to general antioxidants. Its ability to specifically target cardiolipin in the inner mitochondrial membrane distinguishes it from other interventions.

However, the cost, injectable administration, and limited long-term safety data mean SS-31 may not be suitable for everyone. Those considering it should weigh the potential benefits against the practical challenges and uncertainties.

Research continues to explore SS-31 for conditions beyond Barth syndrome. Future clinical trial results may expand our understanding of its therapeutic potential and optimal applications.

Disclaimer: This guide is for informational purposes only and does not constitute medical advice. SS-31 sold by research peptide vendors is intended for laboratory research use only, not human consumption. Always consult a licensed healthcare provider before considering any peptide or medication. The FDA-approved version (Forzinity) is only available by prescription for Barth syndrome.